Protective effects of thymosin β4 in a mouse model of lung fibrosis

Annals of the New York Academy of Sciences

Volumn 1269, Issue 1, 2012, Pages 69-73

  Conte, Enrico ^a   Genovese, Tiziana ^b   Gili, Elisa ^a   Esposito, Emanuela ^b   Iemmolo, Maria ^a   Fruciano, Mary ^a   Fagone, Evelina ^a   Pistorio, Maria Provvidenza ^a   Crimi, Nunzio ^a   Cuzzocrea, Salvatore ^b   Vancheri, Carlo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Bleomycin; Fibrosis; Inflammation; Lung; Mouse; Thymosin 4

Indexed keywords

BLEOMYCIN; THYMOSIN BETA4;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; IN VIVO STUDY; LUNG FIBROSIS; NONHUMAN;

EID: 84867377720     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06694.x     Document Type: Article

References (24)

1. Green, F.H. 2002. Overview of pulmonary fibrosis. Chest 122: 334S-339S.
2. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. 2002. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit Care Med. 165: 277-304.
3. Goldstein, A.L., E. Hannappel & H.K. Kleinman 2005. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11: 421-429.
4. Huff, T., C.S. Muller, A.M. Otto, et al 2001. beta-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 33: 205-220.
5. Sosne, G., P. Qiu & M. Kurpakus-Wheater 2007. Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent. Clin. Ophthalmol. 1: 201-207.
6. Sosne, G., P. Qiu, P.L. Christopherson & M.K. Wheater 2007. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp. Eye Res. 84: 663-669.
7. Sosne, G., P.L. Christopherson, R.P. Barrett & R. Fridman 2005. Thymosin-beta4 modulates corneal matrix metalloproteinase levels and polymorphonuclear cell infiltration after alkali injury. Invest Ophthalmol. Vis. Sci. 46: 2388-2395.
8. Young, J.D., A.J. Lawrence, A.G. MacLean, et al 1999. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5: 1424-1427.
9. Girardi, M., M.A. Sherling, R.B. Filler, et al 2003. Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. Immunology 109: 1-7.
10. Badamchian, M., M.O. Fagarasan, R.L Danner, et al 2003. Thymosin beta(4) reduces lethality and down-regulates inflammatory mediators in endotoxin-induced septic shock. Int. Immunopharmacol. 3: 1225-1233.
11. Ben-Neriah, Y. & M. Karin 2011. Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat. Immunol. 12: 715-723.
12. Ghosh, S. & M.S. Hayden 2008. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8: 837-848.
13. Qiu, P., M.K. Wheater, Y. Qiu & G. Sosne 2011. Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J. 25: 1815-1826.
14. Sopko, N., Y. Qin, A. Finan, et al 2011. Significance of thymosin beta4 and implication of PINCH-1-ILK-alpha-parvin (PIP) complex in human dilated cardiomyopathy. PLoS One 6: e20184.
15. Ho, J.H., C.H. Chuang, C.Y. Ho, et al 2007. Internalization is essential for the antiapoptotic effects of exogenous thymosin beta-4 on human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 48: 27-33.
16. Ho, J.H., K.C. Tseng, W.H. Ma, et al 2008. Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage. Br. J. Ophthalmol. 92: 992-997.
17. Kumar, S. & S. Gupta 2011. Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblasts. PLoS One 6: e26912.
18. Bock-Marquette, I., A. Saxena, M.D. White, et al 2004. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432: 466-472.
19. Barnaeva, E., A. Nadezhda, E. Hannappel, et al 2007. Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells. Ann. N.Y. Acad. Sci. 1112: 154-160.
20. Cavasin, M.A., T.D. Liao, X.P. Yang, et al 2007. Decreased endogenous levels of Ac-SDKP promote organ fibrosis. Hypertension 50: 130-136.
21. Peng, H., O.A. Carretero, D.R. Brigstock, et al 2003. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension. Hypertension 42: 1164-1170.
22. Rhaleb, N.E., H. Peng, X.P. Yang, et al 2001. Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension. Circulation 103: 3136-3141.
23. De, S.M., R. Inzitari, S.L. Bosello, et al 2011. beta-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up. Respir. Res. 12: 22.
24. Ashcroft, T., J.M. Simpson & V. Timbrell 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41: 467-470.